Taysha Gene Therapies Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
TSHA Nasdaq 8731 https://tayshagtx.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Taysha Gene Therapies Inc

Certain Biotech Investors Get an Early Look at Results. Is That Fair? - Apr 15th, 2024 9:30 am
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Apr 5th, 2024 12:00 pm
News Flash: Analysts Just Made A Notable Upgrade To Their Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Forecasts - Mar 24th, 2024 12:17 pm
Taysha Gene Therapies Full Year 2023 Earnings: Beats Expectations - Mar 21st, 2024 10:34 am
Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Q4 2023 Earnings Call Transcript - Mar 20th, 2024 3:19 pm
Q4 2023 Taysha Gene Therapies Inc Earnings Call - Mar 20th, 2024 12:01 pm
Taysha Gene Therapies Reports Full Year 2023 Financial Results and Provides Corporate and Clinical Updates - Mar 19th, 2024 8:01 pm
Taysha Gene Therapies to Release Full-Year 2023 Financial Results, Provide Corporate and Clinical Updates and Host Conference Call on March 19 - Mar 14th, 2024 8:26 pm
Taysha Gene Therapies Announces Updates to TSHA-102 Clinical Program in Rett Syndrome - Feb 29th, 2024 1:00 pm
Taysha Gene Therapies Provides Update on Deprioritized Pipeline Programs - Feb 15th, 2024 9:01 pm
Owning 39% shares,institutional owners seem interested in Taysha Gene Therapies, Inc. (NASDAQ:TSHA), - Feb 13th, 2024 10:54 am
7 Micro-Cap Stocks That Could Majorly Surprise Investors - Jan 31st, 2024 7:23 pm
Taysha Gene Therapies Announces Poster Presentation on TSHA-102 in Rett Syndrome at Upcoming British Paediatric Neurology Association 2024 Annual Conference - Jan 22nd, 2024 1:00 pm
3 Growth Stocks That Could Go Parabolic in 2024 - Jan 15th, 2024 2:30 pm
Taysha Gene Therapies Announces First Pediatric Patient Dosed with TSHA-102 in REVEAL Phase 1/2 Pediatric Trial in Rett Syndrome - Jan 10th, 2024 1:00 pm
Trinity Capital Inc. Provides $40 Million Term Loan to Taysha Gene Therapies - Dec 19th, 2023 12:30 pm
Taysha Gene Therapies Announces Expanded Eligibility in REVEAL Phase 1/2 Adult Trial to Include Adolescent Rett Syndrome Patients - Nov 29th, 2023 1:00 pm
Insider Buying: Taysha Gene Therapies Board Observer Bought US$163k Of Shares - Nov 24th, 2023 10:05 am
Party Time: Brokers Just Made Major Increases To Their Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Earnings Forecasts - Nov 19th, 2023 12:03 pm
Analysts Are Upgrading Taysha Gene Therapies, Inc. (NASDAQ:TSHA) After Its Latest Results - Nov 17th, 2023 10:16 am